跳至主要内容
临床试验/IRCT20191223045861N1
IRCT20191223045861N1已完成3 期

Effect of vitamin D supplementation on flow-mediated dilatation (FMD), Oxidized LDL (oxLDL) and Intracellular adhesion molecule 1 (ICAM1) in type 2 diabetic patients with hypertension.

Oroumia University of Medical Sciences0 个研究点目标入组 46 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 65 years(—)
性别
All

入选标准

  • At least 5 years diabetes history based on self-reported
  • Diabetes control with metformin, Glibenclamide, glitazone, Gliclazide or a combination of these
  • Blood pressure control with any of the Angiotensin receptor blockers (ARB), ACE Inhibitor, Calcium channel blockers (CCB), Thiazide diuretics or a combination of these

排除标准

  • Pregnancy and lactation
  • Gastrointestinal diseases such as malabsorption
  • History of cardiovascular problems
  • Kidney? liver and other endocrine diseases
  • Type 1 diabetes
  • The consumption of vitamin D and multivitamin mineral supplements over the past 3 months
  • Drugs affecting vitamin D and calcium metabolism,
  • Insulin therapy
  • Weight loss medications such as Orlistat

研究者

发起方
Oroumia University of Medical Sciences

相似试验